The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Size Of The Assisted Reproductive Technology Market Progress Through 2030?

The assisted reproductive technology market has demonstrated substantial growth in recent years. Its valuation is anticipated to climb from $37.06 billion in 2025 to $40.46 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.2%. The expansion observed in prior periods was largely influenced by factors such as an increase in the prevalence of infertility, the rising trend of maternal age, the expansion of fertility clinics, the wider availability of assisted reproductive procedures, and the growing societal acceptance of ART treatments.

The assisted reproductive technology market is anticipated to experience substantial expansion in the coming years. It is projected to reach $56.96 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.9%. This growth during the forecast period can be primarily attributed to factors such as the increasing embrace of precision fertility diagnostics, greater investments in fertility treatment facilities, the broadening of genetic testing applications, a rising preference for minimally invasive procedures, and enhanced healthcare expenditure on reproductive health. Key trends expected over the forecast period encompass the increasing integration of advanced embryo screening techniques, a surge in the utilization of frozen embryo and egg banking, an escalating need for personalized fertility solutions, the extended application of genetic testing within ART procedures, and an intensified emphasis on improving treatment success rates.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5489&type=smp

Which Growth Drivers Are Expected To Support The Assisted Reproductive Technology Market Forward?

An increasing incidence of infertility is projected to boost the assisted reproductive technology market in the foreseeable future. Infertility is characterized by the inability to conceive after one year of regular, unprotected sexual activity. This condition impacts both genders and is commonly identified when conception is unsuccessful. Assisted reproductive technology (ART) serves as a treatment for infertility, with such therapies encompassing methods involving both female eggs and male sperm. For example, the World Health Organization (WHO), an international public health body headquartered in Switzerland, reported in April 2023 that millions globally of reproductive age face infertility, impacting their families and communities. Globally, approximately 1 in 6 adults, equating to about 17.5% of the worldwide adult population, contend with infertility. Consequently, the growing prevalence of infertility cases propels the expansion of the assisted reproductive technology market.

What Are The Major Segment Categories Within The Assisted Reproductive Technology Market?

The assisted reproductive technology market covered in this report is segmented –

1) By Diagnosis: Hysterosalpingography, Ovarian Reserve Testing, Genetic Testing

2) By Procedure Type: Fresh Non-Donor, Fresh Donor, Frozen Donor, Frozen Non-Donor, Embryo Or Egg Banking

3) By End-User: Hospitals, Fertility Clinics, Other End-Users

Subsegments:

1) By Hysterosalpingography (HSG): X-ray HSG, Sonohysterography (SHG)

2) By Ovarian Reserve Testing: Follicle Stimulating Hormone (FSH) Testing, Anti-Müllerian Hormone (AMH) Testing, Antral Follicle Count (AFC) via Ultrasound

3) By Genetic Testing: Preimplantation Genetic Testing (PGT), Carrier Screening Tests, Genetic Compatibility Testing

What Trends Are Influencing The Future Of The Assisted Reproductive Technology Market?

Major companies in the assisted reproductive technology market are concentrating on creating advanced solutions, such as next-generation sequencing (NGS)-based testing kits, to enhance chromosomal analysis, improve embryo selection, and boost the success rates of fertility treatments. NGS-based preimplantation genetic testing involves research-use technologies that allow for a comprehensive assessment of chromosomal abnormalities in embryos, thereby supporting informed decision-making during IVF and ICSI procedures. For instance, in July 2023, Thermo Fisher Scientific Inc., a US-based biotechnology company, introduced two next-generation sequencing-based products, the Ion ReproSeq PGT-A Kit and the Ion AmpliSeq Polyploidy Kit, to support preimplantation genetic testing for aneuploidy (PGT-A). Developed for reproductive health laboratories, these assays are the initial research-use products of their kind and are compatible with the Ion Torrent Genexus Integrated Sequencer, facilitating a simplified workflow from sample processing to aneuploidy analysis. PGT-A testing aids in detecting chromosomal abnormalities in embryo samples, and these new solutions aim to advance scientific understanding, improve pregnancy success rates, and promote healthier outcomes for future generations. The Genexus platform further streamlines the research process through its integrated templating, sequencing, and data analysis, while the Ion AmpliSeq Polyploidy Panel kit offers improved quality control features to detect contamination, avoid sample mix-ups, and identify triploidy in embryos, thus reinforcing technological progress within the assisted reproductive technology market.

Which Organizations Are Involved In The Assisted Reproductive Technology Market?

Major companies operating in the assisted reproductive technology market are Cooper Surgical Inc., Ferring Pharmaceuticals Ltd., Hamilton Thorne Ltd., Merck KGaA, Genea Limited, California Cryobank, European Sperm Bank, OvaScience Inc., Bloom IVF Centre, Vitrolife AB, FUJIFILM Irvine Scientific Inc., Nidacon International AB, Monash IVF Group Ltd., Cook Medical, INVO Bioscience Inc., Thermo Fisher Scientific Inc., Anecova Sa, Carolinas Fertility Institute, Microm Ltd., Inception Sciences Inc., Progyny Inc., Oxford Gene Technology IP Ltd., IVI-RMA Global, Boston IVF, CARE Fertility Group, Virtus Health, Reproductive Medicine Associates of New York, Shady Grove Fertility, CCRM Fertility, New Hope Fertility Center, Houston Fertility Institute, Pacific Fertility Center, RMA of New Jersey, Sher Fertility Institute, IVF Florida, ORM Fertility, HRC Fertility, Arizona Center for Reproductive Endocrinology & Infertility, San Diego Fertility Center, Fertility Centers of Illinois

Access The Complete Assisted Reproductive Technology Market Report:

https://www.thebusinessresearchcompany.com/report/assisted-reproductive-technology-global-market-report

Which Region Commands The Largest Share Of The Assisted Reproductive Technology Market?

Europe was the largest region in the assisted reproductive technology market in 2025. North America was the second-largest region in assisted reproductive technology market. The regions covered in the assisted reproductive technology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Assisted Reproductive Technology Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=5489&type=smp

Browse Through More Reports Similar to the Global Assisted Reproductive Technology Market 2026, By The Business Research Company

Fertility Treatments Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/fertility-treatments-global-market-report

Fertility Services Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/fertility-services-global-market-report

Infertility Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/infertility-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model